(Bloomberg) — Herbalife Nutrition Ltd. managed to convince investors to lend it $600 million so it could buy back shares, an unusual move at a time when companies are borrowing billions of dollars to shore up liquidity during the coronavirus pandemic.
The maker of weight-loss shakes and supplements that counts Carl Icahn as its largest shareholder sold the unsecured debt Wednesday at a yield of 7.875%, down slightly from early unofficial pricing discussions of 8%, according to people familiar with the matter.
Proceeds from the offering will be used for general corporate purposes, which could include the purchase of stock or capital investment, said the people, who asked not to be named discussing a private transaction.
Herbalife products are distributed by a network of direct sellers, rather than through stores, and the company has garnered controversy for its multi-level marketing structure that encourages sellers to recruit others to hawk the products. But the business has fared well during the pandemic.
Net sales increased 7.7% on a year-over-year basis in the first quarter ended March 31, and the company expects only a small dip in preliminary April volumes as a result of the virus, according to an earnings release earlier this month.
“The demand for our products and for our services has gone up around the world,” Chief Executive Officer John Agwunobi said on a recent earnings call.
A representative for Bank of America Corp., which is leading the deal, declined to comment. A representative for the company didn’t respond to a request for comment.
Debt-financed share buybacks haven’t been the priority for companies suffering from sliding revenues during the outbreak. But Herbalife has a history of doing so with its last buyback for $600 million in May 2018, according to data compiled by Bloomberg. It also authorized an ongoing five-year $1.5 billion buyback program in October 2018.
The new 5.25-year bond yields slightly more than the company’s existing $400 million of 7.25% unsecured notes due in 2026 that last traded at 99.75 cents on the dollar, according to Trace data.
Moody’s Investors Service rated the bonds B1, or four levels below investment grade. While the company has good profitability, cash flow and geographic diversity, there are parts of its business model that are fragile, Moody’s analyst Chedly Louis wrote. S&P Global Ratings graded the notes BB-, or one step higher.
Herbalife’s global multi-level marketing structure has been under scrutiny for years by a number of regulatory agencies, and its business model is highly reliant upon its ability to recruit and retain sales representatives around the world, Louis wrote.
The U.S. Securities and Exchange Commission and the Department of Justice are currently investigating whether Herbalife violated the Foreign Corrupt Practices Act over the time period of 2006 through 2016. The company has reached an “understanding in principle” with both agencies and is expected to resolve the investigations soon, according to a May 7 filing.
Herbalife shares gained 1.8% Wednesday, closing at $44.03.
(Updates with final pricing details throughout.)
For more articles like this, please visit us at bloomberg.com
Subscribe now to stay ahead with the most trusted business news source.
©2020 Bloomberg L.P.